Abstract:Background: P38α is a ubiquitous protein kinase, which plays diverse roles in cancers. Surprisingly, P38α functions vary markedly in different cancers (e.g., cancer suppressor vs cancer promoter). However, there is no report on the expression of P38α, the family's most important member, in pancreatic ductal adenocarcinoma (PDAC) and its association with clinicoathological parameters and patients' prognosis. Materials and methods: We retrospectively analyzed 152 patients who underwent surgery and were pathologically diagnosed with PDAC from September 2013 to September 2015. We used immunohistochemistry to detect P38α expression in tumor and adjacent normal tissues. The significance of the association between P38α and clinicopathological parameters was evaluated using the χ² test and t tests. The Kaplan-Meier method was used to assess the association between P38α expression and preoperative carbohydrate antigen 19-9 (CA19-9) levels and patients' overall survival. The Cox regression model was used to analyze the association between clinicopathological parameters, P38α and preoperative CA19-9 levels, and prognosis. Statistical significance was defined as P < 0.05. Results: P38α was expressed in 63.16% tumor tissues of PDAC, which was significantly higher compared with the adjacent normal tissues (26.32%, P < 0.001). High expression of P38α was associated with patients' histological grade (P = 0.013), lymphatic metastasis (P = 0.025) and TNM stage (P = 0.048). The median survival time of the P38α-high group was 9.2 months, which was shorter compared with that of the P38α-low group (17.3 months, P = 0.011). The median survival time of the CA19-9 > 43.63 group was 11.1 months shorter than that of the CA19-9 < 43.63 group (24.8 months, P < 0.001). The Cox regression model revealed that age (P = 0.003), lymphatic invasion (P = 0.015), TNM stage (P = 0.003), histological grade (P < 0.001), preoperative CA19-9 (P = 0.049), and P38α expression (P = 0.008) were statistically significant independent risk factors affecting prognosis. Specifically, overall survival was 28.4 months in the P38α-low and CA19-9 < 43.63 groups, 16.3 months in the P38α-high or CA19-9 > 43.63 groups, and 9.7 months in the P38α-high and CA19-9 > 43.63 groups (P < 0.001). Conclusions: High expression of P38α was significantly associated with histological grade, lymphatic metastasis, TNM stage and prognosis in patients with PDAC. P38α and preoperative CA19-9 levels were independent risk factors affecting the prognosis of PDAC patients. High expression of p38α and preoperative carbohydrate antigen 19-9 indicate poor prognosis in patients with PDAC.

RELATIONSHIP ANALYSIS BETWEEN HUMAN ABO BLOOD GROUP AND PANCREATIC DUCTAL ADENOCARCINOMA

ABO Blood Type, Smoking Status, Other Risk Factors and Prognosis of Pancreatic Ductal Adenocarcinoma

ABO Blood Groups and Expression of Blood Group Antigens of Epithelial Ovarian Cancer in Chinese Women.

ABO Blood Group and Risk of Pancreatic Cancer: a Study in Shanghai and Meta-Analysis.

Multivariable Analysis of Factors Associated with Hospital Readmission Following Pancreaticoduodenectomy for Malignant Diseases

Systematic Reviews and Meta-and Pooled Analyses ABO Blood Group and Risk of Pancreatic Cancer : A Study in Shanghai and Meta-Analysis

High Expression of P38α and Preoperative Carbohydrate Antigen 19-9 Indicate Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma

ABO Blood Group System and Gastric Cancer: a Case-Control Study and Meta-Analysis.

Prognostic value of ABO blood groups in upfront operated pancreatic ductal adenocarcinomas

ABO Blood Types and Cancer Risk—a Cohort Study of 339,432 Subjects in Taiwan

Total Laparoscopic Versus Open Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: a Propensity Score Matching Analysis with Meta-Analysis

Laparoscopic Versus Open Pancreatic Resection for Ductal Adenocarcinoma: Separate Propensity Score Matching Analyses of Distal Pancreatectomy and Pancreaticoduodenectomy.

Clinicopathological Prognostic Factors and Chemotherapeutic Outcome for Two Histopathological Types of Ampulla of Vater Adenocarcinoma

Influence of Jaundice on Pancreatoduodenectomy

Blood Type and Family Cancer History in Relation to Precancerous Gastric Lesions.

Prognostic Values of Common Clinical Parameters in Advanced Pancreatic Ductal Adenocarcinoma: a Large Multicenter Cohort Study of Ten Years

Clinical Epidemiological Analysis of the Relationship Between Pancreatic Cancer and Diabetes Mellitus: Data from a Single Institution in China.

Iloprost as ‘rescue’ therapy for pulmonary hypertension of the neonate

PD-L1 in Pancreatic Ductal Adenocarcinoma: a Retrospective Analysis of 373 Chinese Patients Using an in Vitro Diagnostic Assay.

Relationship between ABO Blood Group Alleles and Pancreatic Cancer Is Modulated by Secretor (FUT2) Genotype, but Not Lewis Antigen (FUT3) Genotype

Re-Evaluation of Abo Gene Polymorphisms Detected in A Genome-Wide Association Study and Risk of Pancreatic Ductal Adenocarcinoma in A Chinese Population